Atrial Fibrillation
CryoCath enrolls first patient in U.S. atrial fibrillation trial
Published in Medical Device Business Week, November 15th, 2006
The U.S. FDA approved trial is designed to demonstrate Arctic Front's clinical and therapeutic effectiveness in treating atrial fibrillation (AF).
The patient was enrolled by Dr. Kevin Wheelan and treated at the Baylor Medical Center in Dallas, Texas. The procedure was considered an acute success. There were no safety concerns noted, including no reports of phrenic nerve injury, thrombosis, or stroke.
"We consider the enrollment and successful treatment of the first patient an important...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
More Articles from Medical Device Business Week
- Avian Influenza
Medco study shows Americans stockpiled Tamiflu over fears of bird flu pandemic - Awards
MedAvant named one of Georgia's fastest growing technology companies - Blood Glucose
Blood glucose meter focuses on essentials of testing - Breast Cancer
Orion Genomics announces collaboration to validate clinical utility of breast cancer screening test - Breast Reconstruction
East Cooper Regional Medical Center surgeons perform innovative breast reconstruction - Business & Finance
Cryo-Cell International reports third quarter 2006 results - More from this issue of Medical Device Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
